Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.62 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.53 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.53 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CASR | P41180 | 1/20 | 0.46 |
| ▸ | LOX | P28300 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | TCF4 | P15884 | 1/20 | 0.45 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1787505 | 0.86 | HDAC4 (0.51) | LOXL2SLC7A5CYP4F2CYP4A11PARP1 | |
| SCHEMBL28346938 | 0.86 | HDAC4 (0.51) | LOXL2SLC7A5CYP4F2CYP4A11PARP1 | |
| SCHEMBL15671512 | 0.84 | LOXL2 (0.58) | LOXL2SLC7A5CYP4F2CYP4A11POLB | |
| SCHEMBL6330723 | 0.84 | LOXL2 (0.58) | LOXL2SLC7A5CYP4F2CYP4A11PARP1 | |
| SCHEMBL18638708 | 0.83 | PARP1 (0.49) | LOXL2SLC7A5CYP4F2CYP4A11PARP1 | |
| SCHEMBL3475787 | 0.82 | LOXL2 (0.54) | LOXL2SLC7A5CYP4F2CYP4A11POLB | |
| SCHEMBL14551931 | 0.82 | LOXL2 (0.54) | LOXL2SLC7A5CYP4F2CYP4A11POLB | |
| SCHEMBL4752633 | 0.82 | ANPEP (0.58) | PARP1CA1CA2CA9ALDH1A1 | |
| SCHEMBL29779050 | 0.82 | LOXL2 (0.54) | LOXL2SLC7A5CYP4F2CYP4A11POLB | |
| SCHEMBL14561093 | 0.82 | LOXL2 (0.54) | LOXL2SLC7A5CYP4F2CYP4A11POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MYRIAD GENETICS, INCORPORATED (US) | 2009-11-05 | — | — | US | disclosed |
| WO-2008135526-A1 | CARBOXYLIC ACID AMIDES AS FACTOR XA INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275583-A1 | ANTIVIRAL COMPOUNDS AND USE THEREOF | MAVS, ZC3HAV1, EIF2AK2 | LOXL2 4050/4885SLC7A5 2550/4885CYP4F2 3246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.